TY - JOUR
T1 - Coronavirus and Homo Sapiens in Coronavirus Disease 2019 (COVID-19)
AU - Natarajan, Pooja
AU - Kanchi, Muralidhar
AU - Gunaseelan, Vikneswaran
AU - Sigamani, Alben
AU - James, Harmon
AU - Kumar, Belani
N1 - Publisher Copyright:
© 2020 Thieme India. All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - The Spanish influenza pandemic of 1918 globally claimed between 50 and 100 million lives. In India, it was referred to as The Bombay Fever and accounted for a fifth of the global death toll. The current outbreak of the novel coronavirus (2019-nCoV), a new human-infecting β-coronavirus, has clearly demonstrated that the size of an organism does not reflect on its ability to affect an entire human population. 2019-nCOV, first detected in December 2019 in Wuhan, China, spread rapidly globally. Disease in humans ranged from flulike symptoms to severe acute hypoxic respiratory failure. The virus appears closely related to two bat-derived severe acute respiratory syndromes (SARS) coronaviruses. Although bats were likely the original host, animals sold at the Huanan seafood market in Wuhan might have been the intermediate host that enabled the emergence of the virus in humans. Under the electron microscope, the SARS-CoV-2 virus grips its receptor tighter than the virus behind the SARS outbreak in 2003 to 2004. The viral particle docks onto the angiotensin-converting enzyme 2 (ACE2) receptor and initiates viral entry. This review discusses the various aspects of the SARS-CoV-2 virus, its structure, pathophysiology, mechanism of interaction with human cells, virulence factors, and drugs involved in the treatment of the disease.
AB - The Spanish influenza pandemic of 1918 globally claimed between 50 and 100 million lives. In India, it was referred to as The Bombay Fever and accounted for a fifth of the global death toll. The current outbreak of the novel coronavirus (2019-nCoV), a new human-infecting β-coronavirus, has clearly demonstrated that the size of an organism does not reflect on its ability to affect an entire human population. 2019-nCOV, first detected in December 2019 in Wuhan, China, spread rapidly globally. Disease in humans ranged from flulike symptoms to severe acute hypoxic respiratory failure. The virus appears closely related to two bat-derived severe acute respiratory syndromes (SARS) coronaviruses. Although bats were likely the original host, animals sold at the Huanan seafood market in Wuhan might have been the intermediate host that enabled the emergence of the virus in humans. Under the electron microscope, the SARS-CoV-2 virus grips its receptor tighter than the virus behind the SARS outbreak in 2003 to 2004. The viral particle docks onto the angiotensin-converting enzyme 2 (ACE2) receptor and initiates viral entry. This review discusses the various aspects of the SARS-CoV-2 virus, its structure, pathophysiology, mechanism of interaction with human cells, virulence factors, and drugs involved in the treatment of the disease.
KW - antiviral treatment
KW - coronavirus spike protein
KW - cytokine storm
UR - http://www.scopus.com/inward/record.url?scp=85209462521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85209462521&partnerID=8YFLogxK
U2 - 10.1055/s-0040-1721190
DO - 10.1055/s-0040-1721190
M3 - Review article
AN - SCOPUS:85209462521
SN - 2456-9224
VL - 4
SP - 121
EP - 131
JO - Journal of Cardiac Critical Care
JF - Journal of Cardiac Critical Care
IS - 2
M1 - JCCC2060004
ER -